Laser treatment of dilated periorbital veins
https://doi.org/10.21518/akh2024-047
Abstract
Delated periorbital veins causing cosmetic discomfort are one of the most common reasons why patients seek treatment at clinics specializing in aesthetic phlebology. The etiology and pathogenesis of the expansion of once-normal veins on the lower and upper eyelids, as well as in the temporal region have not been established. The potential risk factors include various injuries, invasive cosmetic procedures, intake of female sex hormones, exposure to unfavourable environmental conditions, natural skin ageing, heavy sports activities, and sudden body weight loss. It should be noted that dilated periorbital veins can not only cause aesthetic discomfort, but also induce spontaneous haemorrhages into nearby soft tissues. Initially, dilated periorbital veins were treated using various sclerotherapy options or radiofrequency coagulation with a hair-thin electrode. In recent years, owing to the advent of latest laser platforms, especially neodymium activated yttrium-aluminum-garnet (Nd:YAG) ones, percutaneous laser coagulation (PLC) has become the first-choice technique for treating dilated facial veins. The modern long-pulsed Nd:YAG lasers generate 1064 nm laser radiation, which ensures the achievement of target veins located at different depths under the skin's surface, and also demonstrates high affinity towards haemoglobin and its derivatives. In other words, Nd:YAG lasers are the optimal option to treat dilated facial veins, including those in the periorbital region, in patients with any skin phototypes. The multi-application XEO (Cutera) platform designed for photo and laser therapy is the most successful representative of Nd:YAG lasers. The case reports presented in this article highlight the successful treatment of dilated periorbital veins.
About the Authors
V. Yu. Bogachev
Pirogov Russian National Research Medical University;
First Phlebological Center
Russian Federation
Russian Federation
Vadim Yu. Bogachev, Dr. Sci. (Med.), Professor of the Department of Faculty Surgery No. 2, Faculty of Medicine; Phlebologist Surgeon, Scientific Supervisor
1, Ostrovityanov St., Moscow, 117997, Russia
31, Dmitry Ulyanov St., Moscow, 117447, Russia
V. N. Lobanov
First Phlebological Center
Russian Federation
Russian Federation
Victor N. Lobanov, Surgeon, Vascular Surgeon, General Director
31, Dmitry Ulyanov St., Moscow, 117447, Russia
R. Abdosh
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Robear Abdosh, Postgraduate Student of the Department of Faculty Surgery No. 2, Faculty of Medicine
1, Ostrovityanov St., Moscow, 117997, Russia
References
1. Fante RG, Goldman MP. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):433–434. https://doi.org/10.1016/s0161-6420(00)00565-0.
2. Green D. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):442–448. https://doi.org/10.1016/s0161-6420(00)00384-5.
3. Bowes LE, Goldman MP. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg. 2002;28(1):46–51. https://doi.org/10.1046/j.1524-4725.2002.01154.x.
4. Goldman M, Weiss R, Guex JJ, Partsch H, Perrin M, Ramelet AA et al. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. 6th ed. Elsevier; 2017. 464 p. Available at: https://shop.elsevier.com/books/sclerotherapy/goldman/978-0-323-37726-3.
5. Bogachev VYu, Grusha YaO. The first experience of scleroobliteration of superficial periorbital veins. Flebologiya. 2010;(2):17–22. (In Russ.) Available at: https://www.mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023.
6. Weiss RA, Ramelet AA. Removal of blue periocular lower eyelid veins by ambulatory phlebectomy. Dermatol Surg. 2002;28(1):43–45. https://doi.org/10.1046/j.1524-4725.2002.01189.x.
7. Vigo RL, Premoli J. Removal of periocular eyelid veins by ambulatory phlebectomy with a regular crochet hook. Ophthalmic Plast Reconstr Surg. 2012;28(3):219–220. https://doi.org/10.1097/IOP.0b013e318249d420.
8. Bäumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment ofleg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006;155(2):364–371. https://doi.org/10.1111/j.1365-2133.2006.07314.x.
9. Railan D, Parlette EC, Uebelhoer NS, Rohrer TE. Laser treatment of vascular lesions. Clin Dermatol. 2006;24(1):8–15. https://doi.org/10.1016/j.clindermatol.2005.10.026.
10. Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24(2):143–146. https://doi.org/10.1111/j.1468-3083.2009.03357.x.
11. Srinivas CR, Kumaresan M. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77(3):349–368. https://doi.org/10.4103/0378-6323.79728.
12. Travelute Ammirati C, Carniol PJ, Hruza GJ. Laser treatment of facial vascular lesions. Facial Plast Surg. 2001;17(3):193–201. https://doi.org/10.1055/s-2001-17973.
13. Jørgensen GF, Hedelund L, Haedersdal M. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized splitface trial with blinded response evaluation. Lasers Surg Med. 2008;40(5):293–299. https://doi.org/10.1002/lsm.20634.
14. Adamič M, Pavlović MD, Troilius Rubin A, Palmetun-Ekbäck M, Boixeda P. Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology. J Eur Acad Dermatol Venereol. 2015;29(9):1661–1678. https://doi.org/10.1111/jdv.13177.
15. Leng M, Zhao H. Cosmetic treatment needs associated with vascular diseases: An emerging future development trend with in aesthetics. Phlebology. 2022;37(10):754–755. https://doi.org/10.1177/02683555221112270.
16. Gianesini S, Obi A, Onida S, Baccellieri D, Bissacco D, Borsuk D et al. Global guidelines trends and controversies inlower limb venous andlymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology & Aesthetics, 23-25 January 2019. Phlebology. 2019;34(1 Suppl.):4–66. https://doi.org/10.1177/0268355519870690.
17. Major A, Brazzini B, Campolmi P, Bonan P, Mavilia L, Ghersetich I et al. Nd:YAG 1064 nm laser in the treatment of facial andleg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15(6):559–565. https://doi.org/10.1046/j.1468-3083.2001.00354.x.
18. Karsai S, Roos S, Raulin C. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg. 2008;34(5):702–708. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2008/05000/treatment_of_facial_telangiectasia_using_a.16.aspx.
19. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther. 2001;3(4):169–173. https://doi.org/10.1080/14764170160260744.
20. Bevin AA, Parlette EC, Domankevitz Y, Ross EV. Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias. Dermatol Surg. 2006;32(1):7–12. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2006/01000/variable_pulse_nd__yag_laser_in_the_treatment_of.2.aspx.
21. Ross EV, Uebelhoer NS, Domankevitz Y. Use of a novel pulse dye laser for rapid single-pass purpura-free treatment of telangiectases. Dermatol Surg. 2007;33(12):1466–1469. https://doi.org/10.1111/j.1524-4725.2007.33317.x.
22. Bogachev VYu, Manjikian HP, Alukhanyan OA. Percutaneous laser coagulation of dilated intradermal veins: from theory to practice. Ambulatornaya Khirurgiya. 2023;20(2):17–26. (In Russ.) https://doi.org/10.21518/akh2023-035.
23. Iyer S, Fitzpatrick RE. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg. 2005;31(8):898–903. https://doi.org/10.1097/00042728-200508000-00002.
24. Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with thelong-pulsed 1064 nm Nd:YAG laser. Scientific World Journal. 2012;2012:197139. https://doi.org/10.1100/2012/197139.
25. Sarradet DM, Hussain M, Goldberg DJ. Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg. 2003;29(1):56–58. Available at: https://journals.lww.com/dermatologicsurgery/abstract/2003/01000/millisecond_1064_nm_neodymium__yag_laser_treatment.11.aspx.
26. Bogachev VYu, Boldin BV, Alukhanyan OA, Turkin PYu, Lobanov VN. Hyperpigmentation after sclerotherapy: modern possibilities for prevention and treatment. Ambulatornaya Khirurgiya. 2023;20(1):81–93. (In Russ.) https://doi.org/10.21518/akh2023-012.
27. Bogachev VYu, Rosukhovski DA, Borsuk DA, Shonov OA, Manjikian HP, Lobastov KV et al. Russian clinical practice guidelines for the management of C1 clinical class of chronic venous disorders (reticular veins and telangiectasias). Ambulatornaya Khirurgiya. 2020;(3-4): 140–206. (In Russ.) https://doi.org/10.21518/18/1995-1477-2020-3-4-140-206.
28. Eremia S, Li CY. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG Laser: a prospective study of 17 patients. Dermatol Surg. 2002;28(3):244–247. https://doi.org/10.1046/j.1524-4725.2002.01217.x.
29. Carniol PJ, Price J, Olive A. Treatment of telangiectasias with the 532-nm and the 532/940-nm diode laser. Facial Plast Surg. 2005;21(2):117–119. https://doi.org/10.1055/s-2005-872412.
30. Hercogova J, Brazzini B, Hautmann G, Ghersetich I, Lotti T. Laser treatment of cutaneous vascular lesions: face andleg telangiectases. J Eur Acad Dermatol Venereol. 2002;16(1):12–18. https://doi.org/10.1046/j.1468-3083.2002.00355.x.
31. Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed. 2006;22(6):324–332. https://doi.org/10.1111/j.1600-0781.2006.00254.x.
32. Dudelzak J, Hussain M, Goldberg DJ. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009;8(3):227–229. Available at: https://pubmed.ncbi.nlm.nih.gov/19271368/.
33. Bonaparte JP, Ellis DE. Discomfort during Periorbital and Lateral Temporal Laser Vein Treatment: A Double-blind Randomized Controlled Trial. Plast Reconstr Surg Glob Open. 2014;2(5):e159. https://doi.org/10.1097/GOX.0000000000000106.
Review
For citations:
Bogachev V.Yu., Lobanov V.N., Abdosh R. Laser treatment of dilated periorbital veins. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2024;21(2):104-110. (In Russ.) https://doi.org/10.21518/akh2024-047
Views:
1836
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 